butabarbital decreases consequences of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Closely. Coadministration of CYP3A4 inducers may lower sufentanil degrees and efficacy, quite possibly precipitating withdrawal syndrome in people who have produced Bodily dependence to sufentanil. Discontin